Viewing Study NCT03580668


Ignite Creation Date: 2025-12-24 @ 5:41 PM
Ignite Modification Date: 2026-02-22 @ 9:25 PM
Study NCT ID: NCT03580668
Status: COMPLETED
Last Update Posted: 2024-06-18
First Post: 2018-06-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Effectiveness, Safety, Adherence, and Health-related Quality of Life in HIV-1 Infected Adults Receiving Bictegravir/ Emtricitabine/Tenofovir Alafenamide
Sponsor: Gilead Sciences
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module